As of 2025-07-19, the Intrinsic Value of Cullinan Oncology Inc (CGEM) is -15.14 USD. This CGEM valuation is based on the model Peter Lynch Fair Value. With the current market price of 7.53 USD, the upside of Cullinan Oncology Inc is -301.12%.
Based on its market price of 7.53 USD and our intrinsic valuation, Cullinan Oncology Inc (CGEM) is overvalued by 301.12%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -15.14 - -15.14 | -15.14 | -301.12% |
| P/E | (75.06) - (90.20) | (89.35) | -1286.6% |
| DDM - Stable | (15.11) - (36.09) | (25.60) | -440.0% |
| DDM - Multi | (10.45) - (20.30) | (13.88) | -284.4% |
| Market Cap (mil) | 444.35 |
| Beta | 0.75 |
| Outstanding shares (mil) | 59.01 |
| Enterprise Value (mil) | 367.69 |
| Market risk premium | 4.60% |
| Cost of Equity | 14.79% |
| Cost of Debt | 5.00% |
| WACC | 9.85% |